Thoracic radiotherapy (TRT) improved survival in both oligo- and polymetastatic extensive stage small cell lung cancer.

about

Thoracic radiotherapy (TRT) improved survival in both oligo- and polymetastatic extensive stage small cell lung cancer.

Item

http://www.wikidata.org/entity/Q41504138

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Thoracic radiotherapy (TRT) im ...... stage small cell lung cancer.

@en

type

Item

label

Thoracic radiotherapy (TRT) im ...... stage small cell lung cancer.

@en

prefLabel

Thoracic radiotherapy (TRT) im ...... stage small cell lung cancer.

@en

P1476

Thoracic radiotherapy (TRT) im ...... e stage small cell lung cancer

@en

P2093

Chingyun Cheng

http://www.w3.org/2001/XMLSchema#string

Jing Luo

http://www.w3.org/2001/XMLSchema#string

Jun Wang

http://www.w3.org/2001/XMLSchema#string

Lin-Lin Gong

http://www.w3.org/2001/XMLSchema#string

Lu-Jun Zhao

http://www.w3.org/2001/XMLSchema#string

Minglei Kang

http://www.w3.org/2001/XMLSchema#string

Ping Wang

http://www.w3.org/2001/XMLSchema#string

Qing-Song Pang

http://www.w3.org/2001/XMLSchema#string

Zhi-Yong Yuan

http://www.w3.org/2001/XMLSchema#string

P2860

Chemotherapy in addition to supportive care improves survival in advanced non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data from 16 randomized controlled trials

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Thoracic Radiotherapy for Extensive Stage Small-Cell Lung Cancer: A Meta-Analysis.

Consolidative thoracic radiotherapy for extensive stage small cell lung cancer

Small cell lung cancer: where do we go from here?

Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial.

A randomized phase II study of carboplatin with weekly or every-3-week nanoparticle albumin-bound paclitaxel (abraxane) in patients with extensive-stage small cell lung cancer.

Prognostic factors affecting the risk of thoracic progression in extensive-stage small cell lung cancer.

P2888

s41598-017-09775-0

P304

9255

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-017-09775-0

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Li-Ming Xu

P577

2017-08-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28835666

http://www.w3.org/2001/XMLSchema#string

P932

5569074

http://www.w3.org/2001/XMLSchema#string